Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Healthcare Leader Speaks Out On Latest Hospital "Epidemic"
A global healthcare senior executive has called the latest infection threat to confront the NHS "a national epidemic". Whilst Government statements imply that hospital acquired infections are in decline Jim Taylor, a former Smith & Nephew President and now CEO of infection prevention specialist Saniguard International, says that Norovirus is now an increasing threat to our NHS wards. His company is launching PatientGuard this month - an anti-infection kit created specifically for the UK public, designed to help halt the spread of viruses (including Norovirus & H1N1) & bacteria (including MRSA).
generic viagra online
Bike Paths, Other 'Healthy' Infrastructure Projects Proving Controversial
"Attempts to set billions aside for infrastructure projects like bike paths face an uphill battle on Capitol Hill," The Chicago Tribune reports, adding "GOP legislators see no health savings in parks and similar projects," while advocates say preventive efforts will bring down costs. "A draft Senate bill would provide up to $10 billion annually for a "prevention and public health investment fund" -- a portion of which could be used for projects such as bike paths, sidewalks, farmers markets and other community interventions meant to curb chronic and costly conditions like obesity."
News of the day
Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6m Children Die Each Year From These Preventable And Treatable Diseases
PATH and WaterAid America released two new reports that show that the international aid community and developing-country governments are not responding to clear evidence on child mortality by targeting res where the disease burden is greatest. Diarrheal disease, a leading killer of children under age five worldwide, is responsible for the deaths of nearly 1.6 million children annually, yet it receives very little attention from both policymakers and the public. During the 1980s and 1990s, diarrheal disease mortality rates were cut by nearly 50 percent, made possible by wide availability and implementation of lifesaving prevention and treatment interventions.
Public Health

Introducing The Pioneering XTRAC Velocity™ Excimer Laser: Delivers Psoriasis And Vitiligo Treatments Three Times Faster

PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as other products for dermatological applications, announced the availability of its groundbreaking XTRAC Velocity™ Excimer Laser, a device expected to redefine laser treatment options for patients suffering from psoriasis and vitiligo. Two separate independent third-party agencies have confirmed that the XTRAC Ultra® laser, precursor to the XTRAC Velocity excimer laser, is the most accurate, powerful, and fastest excimer laser available to date. PhotoMedex has raised the bar even higher with the Velocity laser, which features an average laser power of up to 7.2 watts delivered to the patient. Velocity"s treatment time is nearly three times faster than PhotoMedex" XTRAC Ultra laser. In performance tests the device has been able to treat lesions of 3,500 cm2 (600 mj/cm2) in 4 minutes, 52 seconds*-roughly 1/3 the time required by the Ultra. Because the innovative Velocity excimer laser can cover a much greater surface area in the average treatment session-up to 20% of the body surface in five minutes versus only 2 to 4% for alternative lasers-it is the first practical alternative to potent pharmaceuticals or full-body UV irradiation for patients with severe psoriasis. "The XTRAC Velocity laser is going to be a game-changer for patients and dermatology practices alike," said Jeff O"Donnell, president of PhotoMedex. "For patients, the Velocity will dramatically shorten treatment times, increase the size and number of lesions that can be treated per session, and open laser therapy as a viable alternative for patients who were not necessarily laser candidates in the past. In fact, for busy dermatology practices, the Velocity will make it practical to treat as many as 32 patients per day." New Touchscreen, Handpiece Controls With a maximum repetition rate of 400 Hz and delivered laser energy of 12 to 18 millijoules/pulse, PhotoMedex" XTRAC Velocity is unparalleled in its power and treatment speed. The new laser system has an unparalleled safety profile and is also highly effective with a long duration of remission-yet laser performance is only the beginning of the unit"s advantages. To increase quality of care for patients as well as increase the clinician"s convenience, the Velocity offers a new full-color touchscreen control interface. The screen and built-in database tracking software goes beyond normal equipment operation to incorporate patient information including ID generation, recognition, treatment history, dosing heuristics and more. Also included for the first time on the Velocity is a touch control handpiece that allows the laser treatment to be delivered more easily compared to conventional footswitch-controlled devices. "Profit Per Treatment" Model Like all the excimer lasers in the PhotoMedex line, the Velocity is available to clinics at no direct cost via a unique consignment-based business model. Thanks to the "Profit per Treatment" model, dermatologists provide Velocity laser therapy to their customers, paying a fee only on treatments rendered. In-service training is provided by a dedicated PhotoMedex clinical specialist. Reimbursement support is also provided by a team of direct employee-insurance specialists who continue to receive positive reviews from both office staff and patients for their dedicated and knowledgeable support. Purchase options and financing for PhotoMedex lasers are available as well. * Treatment time calculations do not include the overhead associated with moving the hand piece. PhotoMedex


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009